Radiological and pathological findings of interval cancers in a multi-centre, randomized, controlled trial of mammographic screening in women from age 40-41 years

Clinical Radiology

Volumn 62, Issue 4, 2007, Pages 348-352

  Evans, A J ^a   Kutt, E ^b   Record, C ^c   Waller, M ^d   Bobrow, L ^e   Moss, S ^d  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b Avon Breast Cancer Screening Unit   (United Kingdom)

^c STOKE MANDEVILLE HOSPITAL   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CALCIFICATION; BREAST CANCER; BREAST TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER SIZE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; BREAST NEOPLASMS; CALCINOSIS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING;

EID: 33847238813     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2006.10.010     Document Type: Article

References (22)

1. Taylor R., Page A., Bampton D., et al. Age-specific interval breast cancers in New South Wales and Meta-analysis of studies of women aged 40-49 years. J Med Screen 11 (2004) 199-206
2. Andersson I., Aspergen K., Janzon L., et al. Mammographic screening and mortality from breast cancer: the Malmo Mammographic Screening Trial. BMJ 297 (1988) 943-948
3. Bjurstam N., Bjorneld L., Duffy S.W., et al. The Gothenburg Breast Screening Trial. First results on mortality, incidence and mode of detection for women ages 39-49 years at randomization. Cancer 80 (1997) 2091-2099
4. Erbas B., Amos A., Fletcher A., et al. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening programme by age: should older women continue screening?. Cancer Epidemiol Biomarkers Prev 13 (2004) 1569-1573
5. Ugnat A.M., Xie L., Morriss J., et al. Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer 90 (2004) 1138-1143
6. Sibbering D.M., Burrell H.C., Evans A.J., et al. Mammographic sensitivity in women under 50 presenting symptomatically with breast cancer. Breast 4 (1995) 127-129
7. De Nunzio M.C., Evans A.J., Pinder S.E., et al. Correlations between the mammographic features of prevalent round screen detected invasive breast cancer and pathological prognostic factors. Breast 6 (1997) 146-149
8. Warren R.M.L., Young J.R., McLean L., et al. Radiology review of the UKCCCR Breast Screening Frequency Trial: potential improvements in sensitivity and lead-time of radiological signs. Clin Radiol 58 (2003) 128-132
9. Evans A.J., Wilson A.R.M., Burrell H.C., et al. Mammographic features of ductal carcinoma in situ (DCIS) present on previous mammography. Clin Radiol 54 (1999) 644-646
10. Moss S., Thomas I., Evans A., et al. Randomised, controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years. Br J Cancer 92 (2005) 949-954
11. Wolfe J.N. Breast parenchymal patterns and their changes with age. Radiology 121 (1976) 545-552
12. Mandelson M., Oestreicher N., Porter P., et al. Breast density as a predictor of mammographic detection: comparison of interval screen-detected cancers. J Natl Cancer Inst 92 (2000) 1081-1087
13. Ciatto S., Visioli C., Paci E., et al. Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer 90 (2004) 393-396
14. Rosenberg R.D., Hunt W.C., Williamson M.R., et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 209 (1998) 511-518
15. Buist D.S., Porter P.L., Lehman C., et al. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 96 (2004) 1432-1440
16. Vitak B., Olsen K., Manson J., et al. Tumour characteristics and survival in patients with invasive breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers. Eur Radiol 9 (1999) 460-469
17. Burrell H., Sibbering D., Wilson A., et al. Screening interval breast cancers: mammographic features and prognosis factors. Radiology 199 (1996) 615-620
18. Amos A.F., Kavanagh A.M., and Cawson J. Radiology Quality Assurance Group of BreastScreen Victoria. Radiological review of interval cancers in an Australian mammographic screening programme. J Med Screen 7 (2000) 184-189
19. De Rijke J.M., Schouten L.J., Schreutelkamp J.L., et al. A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, The Netherlands. J Med Screen 7 (2000) 19-23
20. Meeson S., Young K.C., Wallis M.G., et al. Image features of true positive and false negative cancers in screening mammograms. Br J Radiol 76 (2003) 13-21
21. Ferranti C., Coopmans de Yoldi G., Biganzoli E., et al. Relationship between age mammographic features and pathological tumour characterisics in non-palpable breast cancer. Br J Radiol 73 (2000) 698-705
22. Evans A.J., Kutt E., Record C., et al. Radiological findings of screen-detected cancers in a multi-centre randomized, controlled trial of mammographic screening in women from age 40 to 48 years. Clin Radiol 69 (2006) 784-788